Abstract: A system comprises a computer network and worker machines connected to the computer network. The worker machines store partitions of a distributed database. A master machine is connected to the computer network. The master machine includes a query processor to identify a star query that references a fact table and related dimension tables that characterize attributes of facts in the fact table. Eager aggregation is applied to a query plan associated with the star query. The eager aggregation alters the query plan by moving an aggregation operation before a join operation to form an eager aggregated query plan. An analytical view with data responsive to the eager aggregated query plan is identified. The eager aggregated query plan is revised to form a final query plan. The final query plan references the analytical view. The final query plan is executed to produce query results.

Abstract: A system has a distributed database with database partitions distributed across worker nodes connected by a network. An analytical view recommendation engine defines an analytical view comprising attributes and measures defined prior to the receipt of a query. The analytical view is maintained as a data unit separate from the distributed database. The analytical view recommendation engine includes instructions executed by a processor to identify a poorly performing report, evaluate queries associated with the poorly performing report, create a recommended analytical view to enhance the performance of the poorly performing report, and deploy the recommended analytical view.

Abstract: A computer-implemented system and method of generating a digital retention mesh with one or more morphable regions, the one or more morphable regions corresponding to one or more removed undercut regions,

Abstract: A system comprises a computer network and worker machines connected to the computer network. The worker machines store partitions of a distributed database. A master machine is connected to the computer network. The master machine includes a query processor to identify a star query that references a fact table and related dimension tables that characterize attributes of facts in the fact table. Eager aggregation is applied to a query plan associated with the star query. The eager aggregation alters the query plan by moving an aggregation operation before a join operation to form an eager aggregated query plan. An analytical view with data responsive to the eager aggregated query plan is identified. The eager aggregated query plan is revised to form a final query plan. The final query plan references the analytical view. The final query plan is executed to produce query results.

Abstract: A system comprises a computer network and worker machines connected to the computer network. The worker machines store partitions of a distributed database. A master machine is connected to the computer network. The master machine includes a query processor to identify a star query that references a fact table and related dimension tables that characterize attributes of facts in the fact table. Eager aggregation is applied to a query plan associated with the star query. The eager aggregation alters the query plan by moving an aggregation operation before a join operation to form an eager aggregated query plan. An analytical view with data responsive to the eager aggregated query plan is identified. The eager aggregated query plan is revised to form a final query plan. The final query plan references the analytical view. The final query plan is executed to produce query results.

Abstract: A stable tablet-in-tablet pharmaceutical composition having fixed dose combinations of cyclophosphamide and capecitabine and one or more pharmaceutically acceptable excipient. As disclosed is a process for the preparation thereof, and a method their use in treating cancer diseases.

Abstract: This present invention relates to pharmaceutical compositions comprising cyclophosphamide alone and/or in combination with one or more pharmaceutical active ingredients and one or more pharmaceutically acceptable excipients wherein the cyclophosphamide has D90 particle size less than 100 microns.

Abstract: This present invention relates to pharmaceutical compositions comprising cyclophosphamide alone and/or in combination with one or more pharmaceutical active ingredients and one or more pharmaceutically acceptable excipients wherein the cyclophosphamide has D90 particle size less than 100 microns.

Abstract: A pharmaceutical compositions having fixed dose combinations of capecitabine and cyclophosphamide, processes for the preparation thereof, and their use to treat cancer diseases.